Skip to content
GinjerNews

Swiss Respiratory Biotech Windward Up 7.9% in US Trading Debut

By Avalon Pernell

Windward Bio Group AG shares rose 7.9% in its trading debut, after the company raised about $225 million in an initial public offering and private placement.

This story was published by Bloomberg. Read the full article on their site.

Read the full story at bloomberg.com(opens in a new tab)

More News